Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
[Multiple sclerosis: oral drugs].
Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis.
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
Rate and Predictors of Serious Neurologic Causes of Dizziness in the Emergency Department.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Multiple sclerosis for nurse practitioners.
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.
Laquinimod in the treatment of relapsing remitting multiple sclerosis.
Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
17β-estradiol replacement therapy protects myelin sheaths in the white matter of middle-aged female ovariectomized rats: a stereological study.
Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients.
Modelling the natural history of primary progressive multiple sclerosis.
Acupuncture and multiple sclerosis: a review of the evidence.
Trigeminal neuralgia: A new therapy?
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
PML after natalizumab discontinuation: Few and true?
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.

Pages